Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma'... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen lab... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, participant- and investigator - blinded, placebo-controlled, phase 2a st... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mu... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'Using AS01 adjuvant to improve immune response in older adults through trained immunity'. The follo... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Dose Escalation Trial to Determine the Safety, Tolerance, Maximum Tolerated Dose,and Prel... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab ... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investi... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'Regime for vitamin D maintEnanCe In poSt-operatIVE patients (D-ECISIVE) Randomized Controlled Trial... Read More
Singapore, Aug. 5 -- The Health Sciences Authority received information related to the study titled 'ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Comp... Read More